Daniel Feger
Impact in
-
- Marine Sponges and Natural Products
-
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
Papers in
-
- Histone Deacetylase Inhibitors Research 1
- Oncology 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Peter Proksch (2 shared papers)Wenhan Lin (2 shared papers)Amal H. Aly (2 shared papers)Anthoula Gaigneaux (1 shared paper)Michaël Schnekenburger (1 shared paper)Daowan Lai (1 shared paper)Karsten Siems (1 shared paper)Abdessamad Debbab (1 shared paper)
- Journals
- Journal of Natural Products (2 papers)Cancer Research (2 papers)SLAS DISCOVERY (1 paper)Sensors (1 paper)Chemie Ingenieur Technik (1 paper)
- Partner nations
- GermanyNetherlandsChina
In The Last Decade
Daniel Feger
9 papers receiving 160 citations
Peers
Comparison fields: 5 of 47
- Biotechnology 47
- Pharmacology 74
- Toxicology 13
- Organic Chemistry 62
- Cancer Research 19
Countries citing papers authored by Daniel Feger
This map shows the geographic impact of Daniel Feger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Feger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Feger more than expected).
Fields of papers citing papers by Daniel Feger
This network shows the impact of papers produced by Daniel Feger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Feger. The network helps show where Daniel Feger may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Feger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 91 | |
| 2 | 2014 | 54 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 3 | |
| 5 | 2019 | 3 | |
| 6 | 2014 | 2 | |
| 7 | 2022 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 1 |
About Daniel Feger
Daniel Feger is a scholar working on Molecular Biology, Oncology, Pharmacology, Biophysics and Cancer Research, having authored 9 papers that have together received 161 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers), Spectroscopy Techniques in Biomedical and Chemical Research (2 papers), Microfluidic and Capillary Electrophoresis Applications (2 papers), MicroRNA in disease regulation (1 paper), Quinazolinone synthesis and applications (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Synthesis and Biological Activity (1 paper). The work is most often cited by research in Biotechnology (47 citations), Pharmacology (74 citations), Toxicology (13 citations), Organic Chemistry (62 citations) and Cancer Research (19 citations). Daniel Feger has collaborated with scholars based in Germany, Netherlands and China. Frequent co-authors include Peter Proksch, Wenhan Lin, Amal H. Aly, Anthoula Gaigneaux, Michaël Schnekenburger, Daowan Lai, Karsten Siems, Abdessamad Debbab, Marc Diederich and Carole Seidel. Their work appears in journals such as Journal of Natural Products, Cancer Research, SLAS DISCOVERY, Sensors and Chemie Ingenieur Technik.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.